<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC4195804/results/search/test_trace/results.xml">
  <result pre="humans and animals. •There are no approved drugs for the" exact="treatment" post="of coronavirus infections. •Several SARS-CoV inhibitors, with known mechanisms"/>
  <result pre="optimized versions of such compounds could be beneficial for the" exact="treatment" post="and control of SARS-CoV, the current MERS-CoV and other"/>
  <result pre="been informed of a total of 614 laboratory-confirmed cases of" exact="infection" post="with MERS-CoV (including 181 deaths) primarily in the Middle"/>
  <result pre="are among the first SARS-CoV inhibitors that were discovered by" exact="screening" post="compound libraries using an assay that utilizes a fluorogenic"/>
  <result pre="coronavirus inhibitors Currently, there are no approved drugs for the" exact="treatment" post="of SARS-CoV infection. During the initial outbreak of SARS,"/>
  <result pre="protease inhibitors [85] had some encouraging outcomes, but a definitive" exact="treatment" post="regimen was not clearly established. More recently, a combination"/>
  <result pre="widely available, as some of them are used for the" exact="treatment" post="of some viral infections, such as hepatitis C virus,"/>
  <result pre="drug abuse/overdose, bacterial infections and many others (Interferon and ribavirin" exact="treatment" post="side effects, http://www.hepatitis.va.gov/provider/reviews/treatment-side-effects.asp#S1X). Hence, with the new outbreak of"/>
  <result pre="of a novel family of SARS-CoV protease inhibitors by virtual" exact="screening" post="and 3D-QSAR studiesJ Med Chem4920063485349516759091 34LuI.L.HuangC.F.PengY.H.LinY.T.HsiehH.P.ChenC.T.LienT.W.LeeH.J.MahindrooN.PrakashE.Structure-based drug design of"/>
  <result pre="the helicase activities and replication of SARS coronavirusChem Biol12200530331115797214 46AdedejiA.O.SarafianosS.G.Future" exact="treatment" post="strategies for novel Middle East respiratory syndrome coronavirus infectionFuture"/>
  <result pre="with fusion proteinChem Biol8200164565911451666 51Lieberman-BlumS.S.FungH.B.BandresJ.C.Maraviroc: a CCR5-receptor antagonist for the" exact="treatment" post="of HIV-1 infectionClin Ther3020081228125018691983 52MacArthurR.D.NovakR.M.Reviews of anti-infective agents: maraviroc:"/>
  <result pre="the CCR5 receptor antagonist, UK-427,857, a new agent for the" exact="treatment" post="of HIV infection and AIDSProg Med Chem43200523927115850827 54AnonymousPentafuside. DP"/>
  <result pre="antagonist, UK-427,857, a new agent for the treatment of HIV" exact="infection" post="and AIDSProg Med Chem43200523927115850827 54AnonymousPentafuside. DP 178, T 20Drugs"/>
  <result pre="fusion core complexJ Virol7720038801881112885899 66HofmannH.GeierM.MarziA.KrumbiegelM.PeippM.FeyG.H.GrambergT.PohlmannS.Susceptibility to SARS coronavirus S protein-driven" exact="infection" post="correlates with expression of angiotensin converting enzyme 2 and"/>
  <result pre="infection correlates with expression of angiotensin converting enzyme 2 and" exact="infection" post="can be blocked by soluble receptorBiochem Biophys Res Commun31920041216122115194496"/>
  <result pre="L blocks severe acute respiratory syndrome and ebola pseudotype virus" exact="infection" post="into human embryonic kidney 293T cellsMol Pharmacol78201031932420466822 74StruckA.W.AxmannM.PfefferleS.DrostenC.MeyerB.A hexapeptide"/>
  <result pre="pneumonia: a prospective studyLancet36120031767177212781535 82SungJ.J.WuA.JoyntG.M.YuenK.Y.LeeN.ChanP.K.CockramC.S.AhujaA.T.YuL.M.WongV.W.Severe acute respiratory syndrome: report of" exact="treatment" post="and outcome after a major outbreakThorax59200441442015115870 83BoothC.M.MatukasL.M.TomlinsonG.A.RachlisA.R.RoseD.B.DwoshH.A.WalmsleyS.L.MazzulliT.AvendanoM.DerkachP.Clinical features and"/>
  <result pre="respiratory syndrome: a preliminary studyJAMA29020033222322814693875 85ChuC.M.ChengV.C.HungI.F.WongM.M.ChanK.H.ChanK.S.KaoR.Y.PoonL.L.WongC.L.GuanY.Role of lopinavir/ritonavir in the" exact="treatment" post="of SARS: initial virological and clinical findingsThorax59200425225614985565 86FalzaranoD.de WitE.MartellaroC.CallisonJ.MunsterV.J.FeldmannH.Inhibition"/>
 </snippets>
</snippetsTree>
